What Immunito AI does
Founded in 2020, Immunito AI operates in Health Tech industry. Initially focusing on leveraging AI to streamline the antibody discovery process, the company has evolved to enhance the efficiency and effectiveness of biologic drug development. Immunito AI has joined various industry programmes to advance its technological capabilities and broaden its reach within the sector. Competing with companies such as Peptris Technologies and Generic Aadhaar.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Immunito AI yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.